-
-
21/05/2025 22/05/2025 America/Toronto Pharma & Biotech Patent Litigation in Europe Pharma & Biotech Patent Litigation in Europe
May 21 – 22, 2025
Radisson Blu Hotel, Amsterdam City Centre, Amsterdam
Please visit https://www.c5-online.com/pharma-biotech-patent-litigation/ for more information and updates. Radisson Blu Hotel, Amsterdam City Centre, Amsterdam true DD/MM/YYYY 1440 use-title -
-
-
21/05/2025 22/05/2025 America/Toronto Pharma & Biotech Patent Litigation in Europe Pharma & Biotech Patent Litigation in Europe
May 21 – 22, 2025
Radisson Blu Hotel, Amsterdam City Centre, Amsterdam
Please visit https://www.c5-online.com/pharma-biotech-patent-litigation/ for more information and updates. Radisson Blu Hotel, Amsterdam City Centre, Amsterdam true DD/MM/YYYY 1440 use-title -
Europe’s Gold Standard Event for Pharma & Biotech Patent Litigation.
C5’s Pharma & Biotech Patent Litigation in Europe Forum brings together top litigators and in-house counsel to explore the latest legal and regulatory developments impacting the life sciences industry.
Gain practical insights on the evolving Unified Patent Court (UPC), international patent litigation strategies, and the EU’s regulatory changes. Key topics include strategies for navigating UPC litigation and securing preliminary injunctions, understanding the evolving EU regulatory landscape and its impact on IP rights, and exploring emerging trends in biosimilar and biologic patent litigation across global markets.
Join us for two days of engagement with the European life sciences patent bar, and shape the future of pharma and biotech litigation.
Key Topics
Mastering UPC Litigation Strategies: Filing, pleading, and securing preliminary injunctions under the Unified Patent Court
Patent Rights Beyond the UPC: Strategies for defending and enforcing patents in key jurisdictions, including the UK, Brazil, and China
Exclusive Insights from the UPC Bench: Hear directly from UPC judges on best practices and emerging trends
Plausibility and Inventive Step: Understand the impact of the EPO’s G2/21 decision on patent prosecution and litigation
EU Competition Law and Pharma Patents: Prepare for new enforcement trends and their economic impacts
CRISPR/Cas9 and Gene Therapy: Navigate the evolving regulatory and IP landscape for gene therapy medicinal products (GTMPs)
WHO SHOULD ATTEND
In-Housel Counsel and Executives from Pharmaceutical and Biotech Companies, including:
- Head of IP
- Head of Patent Litigation
- VP-Intellectual property
- Scientific Director
- Head of Legal / Legal Affairs
- Principal Patent Examiner
- Head of Global Strategy
- Director Innovation, IP and Portfolio Management
- R&D Patent manager
- Associate VP & Director of Technology Licensing & Commercialization
- Patent Counsel
Law firm attorneys with practices in:
- Intellectual Property and Patent Law
- Life Sciences
- European Patent Law
- US Patent
OUR PRIOR DELEGATES SAY IT BEST
The combination of networking opportunities with people from various backgrounds. Concise overview over the most relevant topics.
Good networking opportunities with in-house Counsel and leading IP law firms. Hot topics, great speakers and convenient number of attendants.
Important subject matters to discuss presented by renowned specialists. An important conference to attend.
Sponsor Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Aaron Goldstein
Senior Business Development Manager
Phone: 201-282-7274 | Email
Related Conferences
